According to the National Institute of Drug Abuse, 'Sex hormones can make women more sensitive than men to the effects of some drugs.' Details
The CDC report released Thursday looked into cannabis-involved emergency department visits among people under 25 years old during the pandemic. It found a spike in visit rates within the time period compared to 2019, most significantly in children under 14.
When looking into the gendered differences, the CDC said females may be more likely than males to use cannabis to cope with stress, noting a 2021 study that found young females were more likely to use harmful coping mechanisms when stressed. Specific reasons for the higher rates are unclear, but age and the drug's expanded legalization could be adding to the higher rates, the CDC noted. Plus, its wider use and availability has made young people less likely to associate cannabis with risk, it said.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Lifeguard shortage worrying East Bay recreation centers amid heat waveWith the intense heat coming to the Bay Area this weekend, several East Bay recreation centers say they’re worried they don’t have enough staff to keep their pools open.
Les mer »
Birth-adoption centers and free education can replace abortion clinics | PennLive lettersLet's spend more money on education and less money on weapons.
Les mer »
HonorHealth to acquire 26 Arizona urgent care centers from FastMedAfter jointly operating 26 urgent care centers with FastMed for the past three years, Scottsdale-based HonorHealth is now buying out its partner's interest in the venture.
Les mer »
Cooling centers save lives in a heat wave — if you can get thereAs U.S. cities again confront dangerous heat waves — including triple-digit temperatures across southern and western states — many cities are recommending that vulnerable groups seek refuge at cooling centers.
Les mer »
Gilead Sciences says FDA has approved Veklury in COVID patients with severe kidney diseaseGilead Sciences Inc. said Friday the U.S. Food and Drug Administration has approved the use of its Veklury, or remdesivir, for patients with severe renal...
Les mer »